EQUITY RESEARCH MEMO

K&P Scientific LLC

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)60/100

K&P Scientific LLC is a specialized pharmacology and toxicology consulting firm exclusively serving the ophthalmic drug development sector. Founded in 2012 and based in Cambridge, MA, the company provides preclinical and clinical consulting services to pharmaceutical companies, biotech startups, investors, and CROs. By leveraging deep scientific expertise and a global network of key opinion leaders, K&P Scientific drives innovation in ocular therapeutics. Its consulting model allows it to support a wide range of clients without the capital intensity of drug development, positioning it as a critical partner in the ophthalmology space.

Upcoming Catalysts (preview)

  • Q4 2026New major client engagement or partnership with a top ophthalmology pharma70% success
  • Q2 2027Expansion of service offerings into gene therapy or cell therapy for ocular indications50% success
  • Q3 2026Hiring of a high-profile scientific advisor or key opinion leader60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)